Cargando…
LPTO-09. INTRATHECAL TOPOTECAN FOR LEPTOMENINGEAL METASTASIS IN SOLID TUMORS: THE MD ANDERSON EXPERIENCE
BACKGROUND: Leptomeningeal metastasis (LM) is a devastating complication of cancer resulting in progressive neurologic decline. Although intrathecal (IT) methotrexate and cytarabine are commonly used for solid tumor LM, we routinely use IT topotecan due to previously demonstrated similar efficacy an...
Autores principales: | Sinicrope, Kaylyn D, Barata, Pedro, Walker, Julie, Tremont-Lukats, Ivo W, Groves, Morris, Loghin, Monica, Seligman, Christa, Ferguson, Sherise, Weathers, Shiao-Pei, Penas-Prado, Marta, Kamiya-Matsuoka, Carlos, Harrison, Rebecca, Tummala, Sudhakar, Trevino, Christopher R, Peinado, Shanta, Murthy, Rashmi K, Seyedeh, Dibaj, de Groot, John, O’Brien, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213302/ http://dx.doi.org/10.1093/noajnl/vdz014.032 |
Ejemplares similares
-
LPTO-08. INTRATHECAL TRASTUZUMAB PLUS/MINUS IT TOPOTECAN FOR PATIENTS WITH HER2+ BREAST CANCER AND LEPTOMENINGEAL METASTASIS
por: Trevino, Christopher R, et al.
Publicado: (2019) -
LPTO-01. LEPTOMENINGEAL METASTASIS FROM OVARIAN CARCINOMA TREATED WITH SYSTEMIC HIGH-DOSE METHOTREXATE
por: Coffee, Elizabeth, et al.
Publicado: (2019) -
LPTO-06. A NOVEL BRAIN-PERMEANT CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS
por: Deng, Jiaojiao, et al.
Publicado: (2019) -
LPTO-10. ASSESSMENT OF LEPTOMENINGEAL CARCINOMATOSIS DIAGNOSIS AND OUTCOMES FROM 2005 TO 2015 AT THE OHIO STATE UNIVERSITY
por: Williams, Nicole, et al.
Publicado: (2019) -
LPTO-02. INTRATHECAL (IT) TRASTUZUMAB (T) FOR THE TREATMENT OF LEPTOMENINGEAL DISEASE (LM) IN PATIENTS (PTS) WITH HUMAN EPIDERMAL RECEPTOR-2 POSITIVE (HER2+) CANCER: A MULTICENTER PHASE 1/2 STUDY
por: Kumthekar, Priya, et al.
Publicado: (2019)